Synthetic biology strategies for engineering microbial therapeutics in metabolic diseases and cancer
Microbiological Research · 2026
DOI: 10.1016/j.micres.2026.128682 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Microbiological Research, 2026. Verfasst von Boniface Adakole Onoja und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Human Anatomy, Federal University of Health Sciences Otukpo, Benue, Nigeria. Electronic address: bonnyonoja@yahoo.com. Hauptthemen laut MEDLINE: Synthetic Biology, Neoplasms, Metabolic Diseases, Metabolic Engineering. Die Arbeit nennt 140 Literaturangaben.
Abstract (Originalsprache)
Synthetic biology has redefined the therapeutic role of microbes, transforming them from passive commensals or delivery vehicles into programmable living therapeutics capable of sensing, computing, and actuating within host tissues. This transformation is particularly relevant to metabolic disorders and oncological conditions in which pathophysiology is spatially heterogeneous, dynamically regulated and strongly modulated by host-microbe interactions. Engineered bacterial strains and other microbial platforms can be designed to degrade toxic metabolites, replace deficient enzymes or hormones, alter bile-acid and short-chain-fatty-acid profiles, modulate host immunity, and deliver antitumor payloads with spatial precision. In metabolic disorders, early live biotherapeutic programs have demonstrated that engineered Escherichia coli is capable of metabolically degrading phenylalanine in phenylketonuria, thereby providing a clinical proof of mechanism for gut-restricted metabolic interception. In oncology, tumor colonizing bacteria have been engineered to express cytokines, checkpoint inhibitors, lytic toxins, and diagnostic signals, and their application has been recently demonstrated in colorectal cancer detection and localized immunomodulation. Despite this progress, clinical translation remains limited by variable survival and functional activity in vivo, inconsistent engraftment, metabolic and genetic instability, biocontainment requirements, manufacturing complexity, and uncertain dose control, persist in biogenetic engineering. This review highlights chassis selection, circuit architectures, applications for metabolic diseases and cancer, metabolic bottlenecks, and future directions for precision microbial therapeutics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Human Anatomy, Federal University of Health Sciences Otukpo, Benue, Nigeria. Electronic address: bonnyonoja@yahoo.com.
- Department of Biochemistry, Faculty of Basic Medical Sciences, College of Medicine, Federal University of Health Sciences, Otukpo, Benue, Nigeria. Electronic address: agadasamuel22@gmail.com.
- Division of Anatomy, Department of Basic Medical Sciences, College of Medicine, University of Jeddah, Jeddah 23890, Saudi Arabia. Electronic address: wsagad@uj.edu.sa.
- Department of Basic Science, College of Medicine, Princess Nourah bint Abdulrahman University, P.O.Box 84428, Riyadh 11671, Saudi Arabia. Electronic address: hmalmohaimed@pnu.edu.sa.
- Department of Research and Publications, Kampala International University, Kampala 20000, Uganda; Department of Biochemistry, Faculty of Science, Ebonyi State University, Abakaliki, Nigeria. Electronic address: alumesth…
- Department of Physiology, Biochemistry, and Pharmacology; College of Veterinary Medicine; University of Kirkuk, Kirkuk 36001, Iraq. Electronic address: kasim_abass@uokirkuk.edu.iq.
Zitieren
APA
Onoja, B. A., Agada, S. A., Aggad, W. S., Almohaimeed, H. M., Alum, E. U., Abass, K. S., Alum, B. N., & Uti, D. E. (2026). Synthetic biology strategies for engineering microbial therapeutics in metabolic diseases and cancer. Microbiological Research. https://doi.org/10.1016/j.micres.2026.128682
Vancouver
Onoja BA, Agada SA, Aggad WS, Almohaimeed HM, Alum EU, Abass KS, et al. Synthetic biology strategies for engineering microbial therapeutics in metabolic diseases and cancer. Microbiological Research. 2026. doi:10.1016/j.micres.2026.128682
BibTeX
@article{Onoja2026,
author = {Onoja, Boniface Adakole and Agada, Samuel A and Aggad, Waheeb Sami and Almohaimeed, Hailah M and Alum, Esther Ugo and Abass, Kasim Sakran and Alum, Benedict Nnachi and Uti, Daniel Ejim},
title = {Synthetic biology strategies for engineering microbial therapeutics in metabolic diseases and cancer},
journal = {Microbiological Research},
year = {2026},
doi = {10.1016/j.micres.2026.128682}
}
EUVIMED